Determine the necessary mass, volume, or concentration for preparing a solution.
10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Desiccated,Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 ( VMAT2 ).
In Vitro
Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 (VMAT2). Reserpine hydrochloride displays a significant on the density of dopamine D1 receptors (F 2,12 =8.81, p<0.01) in the rat striatum. The affinity (Kd) for the dopamine D1 and D2 receptors during withdrawal from acute and chronic administration of reserpine is not change. IC 50 values of 43.9 and 54.9 μM are obtained after 1 day of treatment with Reserpine hydrochloride in JB6 P+ and HepG2-C8 cells, respectively. Reserpine hydrochloride induces luciferase activity in a dose-dependent manner at concentrations ranging from 5 to 50 μM, and no significant induction is observed at concentrations lower than 5 μM. Results demonstrate that Reserpine hydrochloride (2.5 to 10 μM) also increases the protein expression of Nrf2, HO-1, and NQO1. Reserpine hydrochloride at concentrations of 2.5 to 10 μM decreases the mRNA expression of DNMT1, DNMT3a, and DNMT3b in a concentration-dependent manner in JB6 P+ cells after 7 days of treatment. Reserpine hydrochloride at 10 μM generates a significant difference for DNMT3a expression (p<0.05). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Withdrawal (48 h) from chronic (14-day) but not acute Reserpine hydrochloride administration in a dose of 0.2 mg/kg i.p. produces a significant reduction of the immobility time (F 2,18 =3.68, p<0.05), but increases the climbing time (F 2,18 =4.48, p<0.02), and does not change the swimming time (F 2,18 =1.78; NS) in the forced swim test (FST) in rats . Reserpine hydrochloride at a dose of 5 mg/kg body weight produces significant increase in the urinary excretion profile of vanillylmandelic acid (VMA) compare to control animals. The amount of 5-hydroxyindoleacetic acid (5-HIAA) excreted in animals treated with Reserpine is found to be more than in the control. Dose dependent hypotension is observed with Reserpine hydrochloride. Reserpine hydrochloride at doses of 0.5, 1, 5, 10 and 15 μg/kg produce significant (p<0.01) reduction in blood pressure compare to control. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Assay
JB6 P+ cells are seeded in 96-well plates containing Minimum essential media (MEM) at a density of 1×10 4 cells/mL ( 100 μL/well ) for 1, 3, and 5 days, and HepG2-C8 cells are seeded in plates containing DMEM. After incubation for 24 h, the cells are treated with either DMSO or various concentrations of Reserpine hydrochloride . For JB6 P+ cells, the medium is changed every 2 days for the 3-day and 5-day treatments. Cell viability is assessed using a MTS assay kit according to the manufacturer’s instructions. The absorbance of the formazan product is read at 490 nm, and the cell viability is calculated and compared with the DMSO control group. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:VMAT2
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →No tested application protocols are provided for this item.
General handling suggestions (literature/practice; verify locally):
Always develop assay-specific conditions and validate performance in your system.
Literature context (non-clinical; for scientific orientation only):
Note: This description summarizes established literature mechanisms and is provided strictly for research context. SKU R654460 is for research use only. No medical, diagnostic, or therapeutic claims are made or implied.
This compound is not a buffering agent and is not used to establish or maintain pH. For experimental use, select buffers based on your biological assay (e.g., phosphate, HEPES, citrate) and ensure compatibility with your planned solvent system (often low-percentage DMSO cosolvent). Maintain mildly acidic to neutral pH to preserve solubility of the hydrochloride salt and avoid free-base precipitation.
As a complex bioactive small-molecule salt supplied for research and screening, reserpine hydrochloride is not a process solvent or commodity reagent where greener substitutions are typically evaluated. Green chemistry considerations therefore focus on:
Solvent choices for handling and solution prep:
Waste minimization:
Comparison (general; not item-specific):
Given the compound’s intended use as a reference bioactive, the most impactful green choices lie in solvent reduction, right-sizing experiments, and diligent waste segregation rather than in substituting the compound itself.
This material is provided strictly for research use. It is not supplied as a pharmaceutical excipient and is not intended for human or veterinary use.
Any discussion of historical or clinical use is outside the scope of this product listing and is intentionally omitted. For GMP, pharmacopeial status, or validated manufacturing specifications, consult regulatory references independently; this SKU is for non-GMP research only.
Only limited item-specific physical data are provided with this listing.
Item-specific values:
Literature values and general context (for reference; not product specifications):
For authoritative lot-specific values (melting point, water content, identity spectra), consult the product’s CoA/Spec Sheet.
Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
Interpreting grades (general guidance):
Identity confirmation (typical methods; general):
For the exact grade, assay method, and acceptance criteria applicable to SKU R654460, please refer to the lot-specific CoA/Spec Sheet.
This compound is primarily a bioactive small molecule standard and library member rather than a synthetic reagent. It is not typically employed as a stoichiometric reagent, catalyst, or solvent in chemical transformations.
Research applications (general, non-clinical):
Synthetic chemistry note:
If your objective is synthetic method development, consider simpler indole alkaloid models or the free base form, and consult literature precedents for protecting sensitive ester functions.
Not typically applicable. Reserpine hydrochloride is a complex, sensitive bioactive small molecule that is generally handled as an analyte or standard rather than subjected to synthetic reactions.
For any planned chemical modification, consult primary literature for reserpine derivatizations and conduct small-scale feasibility studies under strictly controlled conditions.
GHS/SDS status from Product Data:
General laboratory safety guidance (literature/practice; not a substitute for SDS):
Always consult the product SDS for definitive hazard classification, exposure limits, and first‑aid measures.
Reserpine hydrochloride is a polar organic salt of a highly oxygenated, lipophilic alkaloid. Solvent choice strongly impacts recovery and solution stability.
Practical miscibility/solubility (literature/general):
Selection guidance:
Small comparison (general):
Confirm solvent and concentration compatibility with your assay system; filter sterilize solutions only if chemically compatible with the membrane material.
Item-specific storage and shipping (from Product Data):
Practical guidance (general best practice; not item-specific specifications):
For definitive shelf-life, retest intervals, and lot-specific stability, consult the CoA/Spec Sheet and SDS for SKU R654460.
Reserpine hydrochloride is the protonated hydrochloride salt of the indole alkaloid reserpine, furnishing a cationic tertiary amine with chloride counter‑ion.
Item-specific identifiers from Product Data:
Literature/structural context (for orientation; not item-specific specifications):
2D structure (described): an indole ring system tethered through an ethylamine chain into a bridged, oxygenated polycyclic ring system; an aromatic trimethoxybenzoyl ester pendant; the tertiary nitrogen is protonated with chloride as counterion.
Reserpine hydrochloride is not typically used as a building block due to its high complexity, multiple sensitive ester linkages, and dense oxygenation pattern. However, in methodological or derivatization studies (literature context):
Functional group landscape:
Representative transformations (reported in the context of natural-product chemistry):
For most laboratories, this compound serves as a reference standard or probe rather than a precursor in multistep synthesis.
Item-specific target data are not provided for this SKU.
Product Data: Target, epitope, species reactivity, clone/isotype (where applicable) — Not specified for this item; refer to CoA/Spec Sheet.
Literature context (for orientation only; not product specification): Reserpine is widely cited as a potent inhibitor of vesicular monoamine transporters (VMAT, especially VMAT2). No guarantee of potency/affinity is implied for this specific item; verify experimentally under your assay conditions.